![Hiroshi Nagashima](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hiroshi Nagashima
Technik-/Wissenschafts-/F&E-Leiter bei PorMedTec Co., Ltd.
Aktive Positionen von Hiroshi Nagashima
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PorMedTec Co., Ltd.
![]() PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments. | Direktor/Vorstandsmitglied | 01.09.2020 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.09.2020 | - |
Karriereverlauf von Hiroshi Nagashima
Statistik
International
Japan | 2 |
Operativ
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
PorMedTec Co., Ltd.
![]() PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments. | Health Technology |
- Börse
- Insiders
- Hiroshi Nagashima
- Erfahrung